Institute for Health Metrics and Evaluation (IHME), 3980 15th Ave. NE, Campus Box #351615, Seattle WA 98195, USA.
J Antimicrob Chemother. 2022 Sep 30;77(10):2586-2587. doi: 10.1093/jac/dkac255.
One of the major challenges for tackling antimicrobial resistance (AMR) is understanding the true burden of resistance and its impact on human health, particularly in locations where surveillance is minimal and data are sparse. The Global Research on AntiMicrobial resistance (GRAM) Project was launched to address these gaps. The scale of the challenge was considerable, but after 4 years of developing a stringent methodological approach and collecting/analysing data from many different sources, the capstone GRAM paper was published in January 2022. This article discusses the key findings and reviews the challenges in scaling-up AMR surveillance systems in a One Health framework. The GRAM Project represents a critical first-step in obtaining the accurate data that are needed to correctly target actions to control AMR.
应对抗微生物药物耐药性(AMR)的主要挑战之一是了解耐药性的真实负担及其对人类健康的影响,特别是在监测最少且数据稀缺的地方。启动全球抗微生物药物耐药性研究(GRAM)项目是为了解决这些差距。挑战规模相当大,但经过 4 年的时间制定了严格的方法,并从许多不同来源收集/分析数据后,2022 年 1 月发表了 GRAM 项目的总结报告。本文讨论了关键发现,并回顾了在“同一健康”框架下扩大 AMR 监测系统的挑战。GRAM 项目是获取准确数据的关键第一步,这些数据是正确确定控制 AMR 行动目标所必需的。